Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join


Oct 06, 2022 4:00 PM - Oct 07, 2022 11:50 PM

(US Eastern Standard Time)

Advancing Diversity, Equity, and Inclusion Across Life Sciences R&D Meeting

Turn insights into action with meaningful exchange across life sciences research and development (R&D) fields.


Meeting | October 6-7

DIA’s Advancing Diversity, Equity, and Inclusion Across Life Sciences R&D Meeting will lead the way in sharing knowledge and fostering coalitions to build greater diversity, equity, and inclusion efforts in the life sciences R&D field.

This program has been developed in collaboration with the Diversity & Inclusion in Life Sciences Community.

Registered attendees will receive access to all session recordings for 2 full months post-conference! This allows you to remain flexible with your schedule and not worry if you need to miss a session. Have a conflict with the dates of the conference? Register anyway and you will receive access to the recordings!

  • Why You Can’t Miss It

    • Emphasize approaches and actionable solutions learned from years of investment from the biopharmaceutical and medical device industry
    • Navigate challenges and best practices that exist in various phases of the drug development lifecycle
    • Inspire interactive and compelling discussions to improve industry accountability and sustainability
    • Advance dialogue among industry leaders, clinical research sites, patients, academia, the FDA, and those in public policy
    • Register Now

  • Learning Objectives

    At the conclusion of this activity, participants should be able to:

    • Describe efforts that advance clinical trial diversity for racial and ethnic minorities, women, and rare diseases
    • Discuss insights on why changing organizational culture to embrace diversity, equity, and inclusion, is an important component of enabling the success of DEI efforts more broadly across multiple areas of R&D
    • Apply learnings on how to set your company up for culture change success
    • Identify challenges within protocol development and design and how they can impact DEI
    • Describe effective ways to integrate community engagement into your clinical trial
    • Identity the many challenges that exist in understanding data from defining it from a race and ethnicity perspective, its real-world application and use, and the importance of equitable data in relation to clinical trial development
    • Implement effective patient engagement strategies into your own organizational practices
    • Evaluate the challenges that impact diversity recruitment, enrollment, and retention in clinical trials
    • Describe methods to increase the diversity of the clinical research talent pipeline

  • Meeting Designed For

    • Diversity, Equity, and Inclusion
    • Clinical Research Operations
    • Medical Affairs and Communication
    • Patient Advocacy, Engagement and Outcomes
    • Professional Education, Training and Development
    • Public Policy and Regulatory Affairs
    • R&D Strategic Planning
    • Register Now


    Want to learn more about Advancing Diversity, Equity, and Inclusion Across Life Sciences R&D Meeting? You've come to the right site!

    Continuing Education


    Highlights & Features

    Program Committee

    • Tamei  Elliott, MS
      Tamei Elliott, MS Associate Director, Scientific Programs
      DIA, United States
    • Richardae  Araojo, PharmD, MS
      Richardae Araojo, PharmD, MS Associate Commissioner for Minority Health, Director, Office of Minority Health
      FDA, United States
    • Dyan  Bryson
      Dyan Bryson VP, Diversity Services
      TOTAL Diversity Clinical Trial Management, United States
    • Diana  Foster, BSN, PhD, MSN
      Diana Foster, BSN, PhD, MSN CEO
      The Association of Diversity In Clinical Trials, United States
    • Karen  Correa, PhD
      Karen Correa, PhD Vice President, Head of Global Clinical Operations
      Takeda, United States
    • Kevin  Freiert, MBA
      Kevin Freiert, MBA Owner and Chief Executive Officer
      Salem Oaks® Consulting, United States
    • Barbara  Goodman, MBA
      Barbara Goodman, MBA President and Chief Executive Officer
      Cures Within Reach, United States
    • Christine  Lee, PharmD, PhD
      Christine Lee, PharmD, PhD Deputy Director, Office of Minority Health and Health Equity (OMHHE), OC
      FDA, United States
    • Alissa  Goodale, DrMed
      Alissa Goodale, DrMed Regulatory Executive Director
      Genentech, A Member of the Roche Group, United States
    • Amy  Sitnick, MA
      Amy Sitnick, MA Vice President, Marketing
      Greenphire, United States
    • Jacqueline  Woodruff, MA
      Jacqueline Woodruff, MA President and Medical Anthropologist
      AnthroSci, United States
    • Stephanie  Young Moss, PharmD, MS
      Stephanie Young Moss, PharmD, MS Pharmacist, Owner
      Integrative Pharmacy Outcomes and Consulting, United States
    • Representative Invited
      Representative Invited DIA, United States

    Digital Learning Catalog

    DIA Learning: eLearning Soultions

    Have an account?

    Be informed and stay engaged.

    Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.